Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study-Reference-Cited by-同舟云学术

Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study

Published:2021-10 Issue:10 Volume:22 Page:1468-1482
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Valle Juan W,Vogel Arndt,Denlinger Crystal S,He Aiwu Ruth,Bai Li-Yuan,Orlova Rashida,Van Cutsem Eric,Adeva Jorge,Chen Li-Tzong,Obermannova Radka,Ettrich Thomas J,Chen Jen-Shi,Wasan Harpreet,Girvan Allicia C,Zhang Wei,Liu Jiangang,Tang Chunlao,Ebert Philip J,Aggarwal Amit,McNeely Samuel C,Moser Brian A,Oliveira Joana M,Carlesi Roberto,Walgren Richard A,Oh Do-Youn

Funder

Eli Lilly and Company

Publisher

Elsevier BV

Subject

Oncology

Reference29 articles.

1. Systemic therapy for biliary tract cancers;Hezel;Oncologist,2008

2. New horizons for precision medicine in biliary tract cancers;Valle;Cancer Discov,2017

3. Cholangiocarcinoma: epidemiology and risk factors;Khan;Liver Int,2019

4. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer;Valle;N Engl J Med,2010

5. Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial;Valle;Lancet Oncol,2015

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoliposomal Irinotecan With Fluorouracil and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Cholangiocarcinoma: A Phase II Study of the AIO Hepatobiliary-YMO Cancer Groups (NIFE-AIO-YMO HEP-0315);Journal of Clinical Oncology;2024-09-10

2. Potential of gamma/delta T cells for solid tumor immunotherapy;Frontiers in Immunology;2024-08-26

3. Exploring the role of the immune microenvironment in hepatocellular carcinoma: Implications for immunotherapy and drug resistance;eLife;2024-08-15

4. Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives;Signal Transduction and Targeted Therapy;2024-08-02

5. Immunological role of Gas6/TAM signaling in hemostasis and thrombosis;Thrombosis Research;2024-06